{"id":947,"date":"2026-01-15T14:14:34","date_gmt":"2026-01-15T13:14:34","guid":{"rendered":"https:\/\/cardiateam.eu\/?p=947"},"modified":"2026-01-15T14:14:34","modified_gmt":"2026-01-15T13:14:34","slug":"risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review","status":"publish","type":"post","link":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/","title":{"rendered":"Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review"},"content":{"rendered":"<p><strong>Authors:<\/strong><\/p>\n<p>Michiel T.H.M. Henkens, Sharon Remmelzwaal, Emma L. Robinson, Adriana J. van Ballegooijen, Arantxa Barandiar\u00e1n Aizpurua, Job A.J. Verdonschot,\u00a0 Anne G. Raafs, Jerremy Weerts, Mark R. Hazebroek, Sandra Sanders-van Wijk, M. Louis Handoko, Hester M. den Ruijter, Carolyn S.P. Lam, Rudolf A. de Boer, Walter J. Paulus,Vanessa P.M. van Empel, Rein Vos, Hans-Peter Brunner-La Rocca1, Joline W.J. Beulens, and Stephane R.B. Heymans<\/p>\n<p>&nbsp;<\/p>\n<p>European Journal of Heart Failure (2020) 22, 1586\u20131597<\/p>\n<p>doi: https:\/\/doi.org\/10.1002\/ejhf.1944<\/p>\n<p>Published: 29 Octobre 2020<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Abstract:<\/strong><\/p>\n<section id=\"ejhf1944-sec-0001\" class=\"article-section__content\">\n<p id=\"ejhf1944-sec-0001-title\" class=\"article-section__sub-title section1\">Aim<\/p>\n<p>Diagnosing heart failure with preserved ejection fraction (HFpEF) in the non-acute setting remains challenging. Natriuretic peptides have limited value for this purpose, and a multitude of studies investigating novel diagnostic circulating biomarkers have not resulted in their implementation. This review aims to provide an overview of studies investigating novel circulating biomarkers for the diagnosis of HFpEF and determine their risk of bias (ROB).<\/p>\n<\/section>\n<section id=\"ejhf1944-sec-0002\" class=\"article-section__content\">\n<p id=\"ejhf1944-sec-0002-title\" class=\"article-section__sub-title section1\">Methods and results<\/p>\n<p>A systematic literature search for studies investigating novel diagnostic HFpEF circulating biomarkers in humans was performed up until 21 April 2020. Those without diagnostic performance measures reported, or performed in an acute heart failure population were excluded, leading to a total of 28 studies. For each study, four reviewers determined the ROB within the QUADAS-2 domains: patient selection, index test, reference standard, and flow and timing. At least one domain with a high ROB was present in all studies. Use of case-control\/two-gated designs, exclusion of difficult-to-diagnose patients, absence of a pre-specified cut-off value for the index test without the performance of external validation, the use of inappropriate reference standards and unclear timing of the index test and\/or reference standard were the main bias determinants. Due to the high ROB and different patient populations, no meta-analysis was performed.<\/p>\n<\/section>\n<section id=\"ejhf1944-sec-0003\" class=\"article-section__content\">\n<p id=\"ejhf1944-sec-0003-title\" class=\"article-section__sub-title section1\">Conclusion<\/p>\n<p>The majority of current diagnostic HFpEF biomarker studies have a high ROB, reducing the reproducibility and the potential for clinical care. Methodological well-designed studies with a uniform reference diagnosis are urgently needed to determine the incremental value of circulating biomarkers for the diagnosis of HFpEF.<\/p>\n<\/section>\n<p><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/10.1002\/ejhf.1944\">Read full publication<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Authors: Michiel T.H.M. Henkens, Sharon Remmelzwaal, Emma L. Robinson, Adriana J. van Ballegooijen, Arantxa Barandiar\u00e1n Aizpurua, Job A.J. Verdonschot,\u00a0 Anne G. Raafs, Jerremy Weerts, Mark R. Hazebroek, Sandra Sanders-van Wijk, M. Louis Handoko, Hester M. den Ruijter, Carolyn S.P. Lam, Rudolf A. de Boer, Walter J. Paulus,Vanessa P.M. van Empel, Rein Vos, Hans-Peter Brunner-La Rocca1,&hellip;<\/p>\n","protected":false},"author":1,"featured_media":949,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-947","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publications"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review - Cardiateam<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review - Cardiateam\" \/>\n<meta property=\"og:description\" content=\"Authors: Michiel T.H.M. Henkens, Sharon Remmelzwaal, Emma L. Robinson, Adriana J. van Ballegooijen, Arantxa Barandiar\u00e1n Aizpurua, Job A.J. Verdonschot,\u00a0 Anne G. Raafs, Jerremy Weerts, Mark R. Hazebroek, Sandra Sanders-van Wijk, M. Louis Handoko, Hester M. den Ruijter, Carolyn S.P. Lam, Rudolf A. de Boer, Walter J. Paulus,Vanessa P.M. van Empel, Rein Vos, Hans-Peter Brunner-La Rocca1,&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/\" \/>\n<meta property=\"og:site_name\" content=\"Cardiateam\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-15T13:14:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"114\" \/>\n\t<meta property=\"og:image:height\" content=\"150\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admin2269\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin2269\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/\"},\"author\":{\"name\":\"admin2269\",\"@id\":\"https:\/\/cardiateam.eu\/#\/schema\/person\/8d3259e0b35aa41c93af6f7c3d340ca4\"},\"headline\":\"Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review\",\"datePublished\":\"2026-01-15T13:14:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/\"},\"wordCount\":357,\"publisher\":{\"@id\":\"https:\/\/cardiateam.eu\/#organization\"},\"image\":{\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/1.webp\",\"articleSection\":[\"Publications\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/\",\"url\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/\",\"name\":\"Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review - Cardiateam\",\"isPartOf\":{\"@id\":\"https:\/\/cardiateam.eu\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/1.webp\",\"datePublished\":\"2026-01-15T13:14:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#primaryimage\",\"url\":\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/1.webp\",\"contentUrl\":\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/1.webp\",\"width\":114,\"height\":150},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/cardiateam.eu\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cardiateam.eu\/#website\",\"url\":\"https:\/\/cardiateam.eu\/\",\"name\":\"Cardiateam\",\"description\":\"Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches\",\"publisher\":{\"@id\":\"https:\/\/cardiateam.eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cardiateam.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cardiateam.eu\/#organization\",\"name\":\"Cardiateam\",\"url\":\"https:\/\/cardiateam.eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/cardiateam.eu\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2019\/07\/cropped-CARDIATEAM-logo-1.png\",\"contentUrl\":\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2019\/07\/cropped-CARDIATEAM-logo-1.png\",\"width\":3486,\"height\":1434,\"caption\":\"Cardiateam\"},\"image\":{\"@id\":\"https:\/\/cardiateam.eu\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/cardiateam.eu\/#\/schema\/person\/8d3259e0b35aa41c93af6f7c3d340ca4\",\"name\":\"admin2269\",\"url\":\"https:\/\/cardiateam.eu\/index.php\/author\/admin2269\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review - Cardiateam","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/","og_locale":"en_GB","og_type":"article","og_title":"Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review - Cardiateam","og_description":"Authors: Michiel T.H.M. Henkens, Sharon Remmelzwaal, Emma L. Robinson, Adriana J. van Ballegooijen, Arantxa Barandiar\u00e1n Aizpurua, Job A.J. Verdonschot,\u00a0 Anne G. Raafs, Jerremy Weerts, Mark R. Hazebroek, Sandra Sanders-van Wijk, M. Louis Handoko, Hester M. den Ruijter, Carolyn S.P. Lam, Rudolf A. de Boer, Walter J. Paulus,Vanessa P.M. van Empel, Rein Vos, Hans-Peter Brunner-La Rocca1,&hellip;","og_url":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/","og_site_name":"Cardiateam","article_published_time":"2026-01-15T13:14:34+00:00","og_image":[{"width":114,"height":150,"url":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/1.webp","type":"image\/webp"}],"author":"admin2269","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin2269","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#article","isPartOf":{"@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/"},"author":{"name":"admin2269","@id":"https:\/\/cardiateam.eu\/#\/schema\/person\/8d3259e0b35aa41c93af6f7c3d340ca4"},"headline":"Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review","datePublished":"2026-01-15T13:14:34+00:00","mainEntityOfPage":{"@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/"},"wordCount":357,"publisher":{"@id":"https:\/\/cardiateam.eu\/#organization"},"image":{"@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#primaryimage"},"thumbnailUrl":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/1.webp","articleSection":["Publications"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/","url":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/","name":"Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review - Cardiateam","isPartOf":{"@id":"https:\/\/cardiateam.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#primaryimage"},"image":{"@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#primaryimage"},"thumbnailUrl":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/1.webp","datePublished":"2026-01-15T13:14:34+00:00","breadcrumb":{"@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#primaryimage","url":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/1.webp","contentUrl":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/1.webp","width":114,"height":150},{"@type":"BreadcrumbList","@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/15\/risk-of-bias-in-studies-investigating-novel-diagnostic-biomarkers-for-heart-failure-with-preserved-ejection-fraction-a-systematic-review\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/cardiateam.eu\/"},{"@type":"ListItem","position":2,"name":"Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review"}]},{"@type":"WebSite","@id":"https:\/\/cardiateam.eu\/#website","url":"https:\/\/cardiateam.eu\/","name":"Cardiateam","description":"Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches","publisher":{"@id":"https:\/\/cardiateam.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cardiateam.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/cardiateam.eu\/#organization","name":"Cardiateam","url":"https:\/\/cardiateam.eu\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/cardiateam.eu\/#\/schema\/logo\/image\/","url":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2019\/07\/cropped-CARDIATEAM-logo-1.png","contentUrl":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2019\/07\/cropped-CARDIATEAM-logo-1.png","width":3486,"height":1434,"caption":"Cardiateam"},"image":{"@id":"https:\/\/cardiateam.eu\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cardiateam.eu\/#\/schema\/person\/8d3259e0b35aa41c93af6f7c3d340ca4","name":"admin2269","url":"https:\/\/cardiateam.eu\/index.php\/author\/admin2269\/"}]}},"_links":{"self":[{"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/posts\/947","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/comments?post=947"}],"version-history":[{"count":2,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/posts\/947\/revisions"}],"predecessor-version":[{"id":950,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/posts\/947\/revisions\/950"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/media\/949"}],"wp:attachment":[{"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/media?parent=947"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/categories?post=947"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/tags?post=947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}